| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
0.0024 |
1 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
1 |